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Abstract
Here we investigate the role of Phosphatidylinositol (4,5) bisphosphate (PIP2) in the physiological activation of primary
murine T cells by antigen presenting cells (APC) by addressing two principal challenges in PIP2 biology. First, PIP2 is a
regulator of cytoskeletal dynamics and a substrate for second messenger generation. The relative importance of these two
processes needs to be determined. Second, PIP2 is turned over by multiple biosynthetic and metabolizing enzymes. The
joint effect of these enzymes on PIP2 distributions needs to be determined with resolution in time and space. We found that
T cells express four isoforms of the principal PIP2-generating enzyme phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
with distinct spatial and temporal characteristics. In the context of a larger systems analysis of T cell signaling, these data
identify the T cell/APC interface and the T cell distal pole as sites of differential PIP2 turnover. Overexpression of different
PIP5K isoforms, as corroborated by knock down and PIP2 blockade, yielded an increase in PIP2 levels combined with
isoform-specific changes in the spatiotemporal distributions of accessible PIP2. It rigidified the T cell, likely by impairing the
inactivation of Ezrin Moesin Radixin, delayed and diminished the clustering of the T cell receptor at the cellular interface,
reduced the efficiency of T cell proximal signaling and IL-2 secretion. These effects were consistently more severe for distal
PIP5K isoforms. Thus spatially constrained cytoskeletal roles of PIP2 in the control of T cell rigidity and spatiotemporal
organization dominate the effects of PIP2 on T cell activation.
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Introduction
Here we address roles of Phosphatidylinositol (4,5) bisphosphate
(PIP2) in T cell activation. Physiological T cell activation occurs in
the cellular interaction between a T cell and an antigen presenting
cell (APC). T cells polarize upon APC contact as driven by the
cytoskeleton [1,2,3], yielding a complex organization of T cell
signaling in dynamic and diverse spatiotemporal patterns [4,5,6].
Prominent is the sustained accumulation of the T cell receptor
(TCR) at the center of the T cell/APC interface [5], an
accumulation pattern that can be associated with efficient T cell
activation [6,7]. A critical outcome of T cell activation is cytokine
secretion, prominently that of the autocrine growth factor IL-2.
PIP2 is a central substrate for second messenger generation and a
well-established regulator of cytoskeletal dynamics in many cell
types [8,9]. Hydrolysis of PIP2 by phospholipase Cc (PLCc) yields
diacylglycerol (DAG) and inositol 1,4,5 trisphosphate (IP3) [10],
two signaling intermediates critical for the induction of T cell IL-2
secretion. In cytoskeletal regulation, PIP2 controls cytoskeleton-
plasma membrane adhesion, the activity of actin severing proteins,
and assembly of endocytic vesicles [9,11,12]. Ezrin Radixin
Moesin (ERM) proteins are a critical mediator of PIP2 function in
the regulation of cytoskeleton-plasma membrane adhesion, as
binding of ERM to PIP2 in the plasma membrane activates them
to strengthen the association of the plasma membrane with the
underlying cortical actin cytoskeleton [13,14]. A first general
challenge in understanding the function of PIP2 in any cell type is
to determine whether the role of PIP2 as a substrate for second
messenger generation or cytoskeletal roles dominate the effects of
PIP2 on cellular activation. In other words, we had to investigate
whether changes in PIP2 levels primarily affected T cell activation
through altered second messenger generation or through altered
cytoskeletal dynamics.
PIP2 is turned over rapidly. The principal biosynthetic pathway
of PIP2 involves phosphorylation of phosphatidylinositol 4-
phosphate by the type I phosphatidylinositol 4-phosphate 5-
kinases (PIP5K) [15]. There are three PIP5K isoforms, a, b, and c
The nomenclature for the a and b isoforms is switched between
humans and mice. We use the more widely employed human
nomenclature. The c isoform has multiple splice variants. The
predominant isoforms are PIP5K c87 (also called c635) and c90
(c661) with the isoforms being denoted by their molecular weight
(87 or 90 kDa) or the number of amino acids (635 or 661). PIP2 is
metabolized through hydrolysis by PLCc or phosphorylation by
phosphatidylinositol 3-kinase (PI3K). Additionally, PIP2 synthe-
sized locally will be dissipated by diffusion [16] unless captured by
scaffolding molecules [17]. PIP2 is also dephosphorylated by
phosphatidylinositol phosphatases [18]. A second key challenge in
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comprehensive insight into how PIP2 turnover is regulated by this
complex group of pathways. As proteins that generate, metabolize,
or function as effectors of PIP2 often display distinct subcellular
localization, the complex PIP2 turnover needs to be analyzed with
resolution in time and space. In other words, we had to determine
where and when PIP2 was synthesized and degraded during T cell
activation. As we have already characterized spatiotemporal
distributions of PIP2 hydrolysis by PLCc and of PIP2 phosphor-
ylation by PIP3K at the T cell/APC interface as part of a larger
systems analysis [6], we focus here on the spatiotemporal
characteristics of PIP2 generation. Once it was better understood
when and where PIP2 was turned over, it was important to
elucidate how the spatiotemporal constraints of PIP2 turnover
govern PIP2 function. In other words, we had to investigate how
manipulation of PIP2 localization affected roles of PIP2 in T cell
activation.
During T cell activation, PIP2 is rapidly synthesized and
hydrolyzed [19,20], even though the spatiotemporal characteristics
of PIP2 synthesis are unknown. Cytoskeletal roles of PIP2 in T cell
activation are also unresolved. They are likely prominent as PIP2
regulates polarization in many related cell types. In macrophages,
PIP2 stabilizes actin at the phagocytic cup [21] and PIP5K c and a
are critical in actin-dependent binding and internalization of
particles [22]. In neutrophils, PIP5K b and c90 are critical for the
turnover of the uropod, a posterior cell extension involved in
adhesion in particular during the extravasation of blood cells from
the vasculature [23,24,25]. In lymphocyte responses to chemo-
kines, hydrolysis of PIP2 is critical in increasing cellular flexibility
during extravasation as associated with inhibition of ERM activity
[26].
Here we address the two general challenges of PIP2 biology, the
balance between roles of PIP2 as a substrate for second messenger
generation versus cytoskeletal roles and the complexity of PIP2
turnover with resolution in time and space with its functional
consequences, in primary T cells. We found that PIP2 synthesis
occurs with distinct spatiotemporal characteristics, as four PIP5K
isoforms (abc87, and c90) displayed distinct dynamic localization
during T cell activation. Overexpression in particular of the distal
PIP5K isoforms, b and c90, yielded a general, yet modest increase
in PIP2 levels combined with distinct isoform-specific changes in
the spatiotemporal distributions of accessible PIP2. Such overex-
pression, as corroborated by knock down and PIP2 blockade,
established that PIP2 primarily controls T cell activation using
spatially constrained cytoskeletal means, by regulating T cell
rigidity and the spatiotemporal organization of T cell signaling
with an emphasis on the T cell distal pole.
Results
Different PIP5Ks are enriched in distinct locations during
T cell activation
As a critical foundation for the understanding of the complexity
of PIP2 turnover in T cells, we determined the spatiotemporal
features of PIP2 synthesis. Primary T cells expressed all three
PIP5K isoforms, a, b, and c with both the c87 and c90 splice
variants of the c isoform (Fig. S1A), as determined by real time
PCR. To elucidate the spatiotemporal distributions of PIP5K
isoforms during the activation of primary T cells, we used in vitro
primed primary T cells from 5C.C7 TCR transgenic mice. The
5C.C7 TCR recognizes peptide 83–102 of moth cytochrome C
(MCC) as presented by the MHC II allele I-E
k. We retrovirally
transduced T cells to express GFP-tagged PIP5K isoforms. We
activated PIP5K expressing T cells with CH27 B cell lymphoma
APC incubated with a high concentration (10 mM) of the MCC
agonist peptide. These were the default T cell activation conditions
for this study.
PIP5K c87 was rapidly recruited to the T cell/APC interface
such that 1 min after interface formation 7468% of cell couples
displayed PIP5K c87 interface accumulation (Figs. 1A, S1B).
PIP5K c87 accumulation was transient such that 5 min after tight
cell coupling only 27611% cell couples with interface accumu-
lation remained (Fig. 1A). Interface accumulation of PIP5K a also
occurred preferentially at the cellular interface, however, in a
more sustained fashion (Figs. 1B, S1C). In contrast, PIP5K b
accumulated almost exclusively at the distal pole (Figs. 1C, S1D).
Within the first two minutes after cell coupling the c90 isoform
preferentially accumulated at the distal pole (Figs. 1D, S1E).
Subsequently however, a substantial portion of PIP5K c90 moved
to the T cell/APC interface reaching about 40% cell couples with
interface accumulation $5 min after tight cell coupling (Fig. 1D).
Interface accumulation of PIP5K c87 without characterization of
its spatiotemporal features has been described before [27].
The determination of the differential localization of the four
PIP5K isoforms is a central contribution to the understanding of
the complex regulation of PIP2 turnover in time and space, in
particular in the context of our wider system analysis of T cell
signaling [6], as discussed below. It also allowed us to manipulate
PIP2 with spatial definition by overexpressing distinct PIP5K
isoforms. For such studies we focused on the two distal PIP5K
isoforms, c90 and b, as it of interest to understand how regulation
of PIP2 levels at the distal pole, away from the location of T cell
signaling at the interface, would impact T cell activation.
PIP5K overexpression yields increased PIP2 levels and
isoform-specific changes in the patterns of accessible
PIP2
To address roles of PIP2 in T cell activation under consideration
of PIP2 localization, we used primarily PIP5K overexpression (Fig.
S2A–C), with knockdown and PIP2 blockade for corroboration.
PIP5K overexpression modestly but significantly (p,0.005)
increased cellular PIP2 levels by ,20% (Figs. 2A, S2D), as
determined by immunostaining for PIP2. These data suggest that
PIP2 levels were tightly controlled in T cells, similar to other cell
types where PIP5K overexpression or deletion often affects PIP2
levels only modestly [22,28,29,30].
To assess consequences of PIP5K overexpression on PIP2
localization, we used the well-established PIP2-binding PLCd PH
domain. As previously described [6], upon tight cell coupling
8365% of cell couples showed PLCd PH-GFP at the T cell/APC
interface (Figs. 2B, S2E). Accumulation was transient, disappear-
ing entirely at 7 min after tight cell coupling (Fig. 2B). Less than 1/
3
rd of the cell couples also displayed transient distal accumulation
of PLCd PH-GFP within the first minute after tight cell coupling
(Fig. 2B).
Upon overexpression of PIP5K b (Fig. 2C, S2F), interface
accumulation of PLCd PH-GFP was almost completely lost, not
exceeding 25% of cell couples with such accumulation at any time
(p,0.001 versus control between time points - 20 and 120 s).
Instead, consistent accumulation of PLCd PH-GFP at the distal
pole was observed in about 1/3
rd of the cell couples at all time
points (p,0.005 versus control at all time points $1 min)(Fig. 2C).
This phenotype is consistent with the exclusive distal accumulation
of PIP5K b itself (Fig. 1C). Overexpression of PIP5K c90 yielded
significantly (p,0.01) increased accumulation of PLCd PH-GFP
at the T cell/APC interface $3 min after its formation with as
many as .50% of the cell couples showing such accumulation
(Fig. 2D, S2G). This enhancement is consistent with translocation
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Interestingly, the early distal presence of PIP5K c90 did not
trigger distal accumulation of PLCd PH-GFP, consistent with a
lack of activators of PIP5K c90 or rapid turnover of PIP2 at the
distal pole at that time. For corroboration we used overexpression
of the interface-localized PIP5K c87 isoform. Such overexpression
yielded a comparable increase in cellular PIP2 levels without
substantial changes in PIP2 localization (Figs. 2A, S2H, S2I). We
also reduced PIP2 generation and access with knockdown of the
PIP5K c isoforms (Fig. S2J) and PIP2 blockade with the PLCd PH
domain as a protein transduction reagent (Fig. S2K).
In summary, PIP5K overexpression yielded a modest but
significant (p,0.005) increase in PIP2 levels together with isoform-
specific changes in PIP2 localization. Isoform-specific effects of
PIP5K overexpression thus will identify location-dependent roles
of PIP2. Additional roles of PIP5K isoforms, such as in scaffolding
as recently described for PIP5K a [31], cannot be ruled out.
PIP5K overexpression impairs IL-2 secretion and proximal
T cell signaling
IL-2 secretion is a key outcome of T cell activation. We
therefore determined its dependence on PIP2. Overexpression of
the distal PIP5K isoforms c90 or b reduced IL-2 secretion to
4464% and 3063% of IL-2 secretion of control T cells,
respectively (Fig. 3A, B)(p,0.005). In contrast, knockdown of
PIP5K c and 5 mM tatPLCd PH modestly but significantly
(p,0.05) enhanced IL-2 secretion by 2669% (1862% in a second
set of experiments, Fig. S3) and 29610%, respectively. Corrob-
orating these data, complete loss of PIP5K c90 leads to an increase
in IL-2 secretion by about 40% [27]. The comparatively modest
size of this enhancement is discussed below. Changes in IL-2
secretion upon overexpression of the interface-associated PIP5K
isoform c87 were not significant (Fig. 3B). These data are
significant, first, as they establish PIP2, in particular distal PIP2,
as a substantial regulator of T cell activation. Second, they are
critical in understanding a potential role of PIP2 as second
messenger precursor. If PIP2 as a substrate for PLCc was central
for mediating effects of PIP2 turnover on T cell activation, mass
action dictates that increased PIP2 generation should yield
increased second messenger levels and thus increased amounts of
IL-2. As our findings run contrary to this expectation, roles of PIP2
as a second messenger substrate were surprisingly minor.
To assess whether PIP2 could function within minutes of T cell
coupling to APCs, the time of drastic cytoskeletal rearrangements,
of maximal biochemical signaling activity, and of the translocation
of transcription factors to the nucleus [6], we addressed
phosphorylation of linker of activated T cells (LAT) and
phospholipase Cc (PLCc). Due to limiting cell numbers, the
determination of tyrosine phosphorylation of LAT (Y191) and
PLCc (Y783) in T cell/APC extracts was restricted to overex-
pression of PIP5K c90 and PIP5K c87 as a non-distal control.
LAT and PLCc phosphorylation were significantly decreased
(p,0.05) upon overexpression of PIP5K c90 by 4666% and
3966% (Fig. 3C, D). In contrast, LAT phosphorylation was
enhanced by 110640% upon knockdown of PIP5K c (p,0.05).
Changes upon overexpression of PIP5K c87 were not significant
(Fig. 3D). Expression of total LAT and PLCc has previously been
shown to not vary during early primary T cell activation [32].
Importantly, effects of PIP2 manipulation on proximal signaling
and IL-2 secretion were extensively matched, consistent with the
suggestion that reduced efficiency of proximal T cell signaling was
a key contributor to decreased IL-2 secretion.
PIP2 regulates T cell spreading and uropod retraction
upon APC contact
As the data on IL-2 secretion suggest that changes in the
amounts and/or localization of PIP2 do not substantially affect T
cell activation through a role of PIP2 as a second messenger
substrate, we next addressed cytoskeletal roles of PIP2. We started
with the control of cellular rigidity, as this is a common function of
PIP2 [15]. Overexpression of PIP5K b, c87, or c90 yielded smaller
initial T cell/APC interface diameters. To account for variable T
cell size, we determined the interface diameter relative to the
diameter of the T cell body. In control T cells at the time of tight
cell coupling, the interface diameter was 1.0260.03 times that of
the T cell body (Fig. 4A). It was significantly reduced to 0.8460.02
to 0.9060.03 times the diameter of the cell body upon
overexpression of each of the PIP5K isoforms (p,0.01 versus
control, no significant differences between PIP5K isoforms),
indicative of increased T cell rigidity.
Impaired T cell spreading became even more evident in
experiments to assess TCR clustering at the T cell/APC interface.
In these experiments the majority of productive T cell/APC
couples displayed accumulation of the TCR at the center of the T
cell/APC interface, as discussed in detail below. In control T cells,
such accumulation was invariably preceded by spreading of a
clearly visible wide lamellum against the APC [6]. However, upon
overexpression of PIP5K isoforms, we observed TCR clustering
without a visible lamellum and the formation of a wide T cell/
APC interface (Fig. S4A) in a substantial portion of the cell
couples. As we could not determine the precise time of cell
coupling and its associated interface diameter in these cell couples
any more, we used an alternate measurement: When we analyzed
all T cell/APC couples with eventual interface accumulation of the
TCR, upon overexpression of PIP5K b, c87, or c90, 2469% to
4168% of the cell couples did not display a lamellum upon cell
coupling (p,0.001 versus control, no significant differences
between PIP5K isoforms)(Figs. 4B, S4A), indicative of most
severely increased T cell rigidity.
As a second cell shape change upon APC coupling, the T cell
retracts its uropod. Overexpression of PIP5K b or c90 specifically
delayed uropod retraction (Figs. 4C, S4B), another indication of
increased T cell rigidity, this time focused on the T cell distal pole.
In control cells at 2 min after tight cell coupling, only 963% of cell
couples still displayed a visible uropod. This percentage was
significantly (p,0.001) increased upon overexpression of PIP5K b
or c90 to 6569% and 5069%.
In summary, overexpression of PIP5K isoforms substantially
interfered with T cell shape changes upon APC contact, both at
the interface and at the distal pole, indicative of increased T cell
rigidity. PIP5K c knockdown or PIP2 blockade altered neither the
interface diameter at T cell/APC coupling nor uropod retraction.
Effects of PIP5K gamma knockdown of PIP2 levels were limited
(Fig. S2J) and blockade of PIP2 by the PLCd PH domain was
Figure 1. Different PIP5K isoforms display distinct spatiotemporal patterns. 5C.C7 T cells were transduced to express GFP-tagged PIP5K
isoforms and activated with CH27 APCs and 10 mM MCC agonist peptide. The graphs show the percentage of cell couples with standard errors that
displayed accumulation of PIP5K c87-GFP (A), a-GFP (B), b-GFP (C), and c90-GFP (D) with the indicated patterns [6] relative to tight cell coupling.
Representative images are given in Fig. S1B–E. Representative movies have been published (c87 [6]) or are given as Movies S1, S2, S3. 34–59 cell
couples were analyzed per condition.
doi:10.1371/journal.pone.0027227.g001
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the more limited nature of these effects. A possible biological
explanation is that T cell flexibility might have already been
maximized upon T cell activation with a strong stimulus, thus
preventing further enhancement upon interference with PIP2
generation or access. Our data on T cell rigidity are corroborated
by data on actin spreading to the edge of the T cell/APC interface
(Fig. S4C–L). Importantly, effects of PIP2 on T cell rigidity and IL-
2 matched. Increased T cell rigidity should interfere with T cell
activation by impairing tight APC coupling and thus extensive
receptor ligand engagement. Accordingly, increased PIP2 gener-
ation in parallel made T cells more rigid and interfered with IL-2
secretion. Interestingly, local features of PIP2 turnover contributed
substantially, as effects of overexpression of distal PIP5K isoforms
were more dramatic both in the control of T cell rigidity, involving
uropod retraction, and IL-2 secretion.
PIP5K overexpression impairs ERM protein
dephosphorylation upon T cell activation
T cell rigidification could be caused by altered ERM protein
function, as ERM proteins link the plasma membrane to the cortical
a c t i nc y t o s k e l e t o ni naP I P 2-dependent fashion. ERM protein activity
requires threonine phosphorylation at residues T567 of Ezrin and
T558 of Moesin [33,34,35,36]. We therefore determined ERM
threonine phosphorylation during T cell activation. TCR engage-
ment was provided by a-CD3 plus a-CD28 antibodies, as the
determination of T cell ERM phosphorylation in T cell/APC
couples, where both cell types contain ERM proteins, is challenging.
Due to limiting cell numbers, these experiments were restricted to
overexpression of PIP5K c90 and PIP5K c87 as a non-distal control.
In non-transduced T cells, ERM phosphorylation dropped signifi-
cantly (p,0.001) to 3569% of the level of non-stimulated T cells
within 2 min of tight cell coupling (Fig. 5). This reduction is indicative
of the increased T cell flexibility required to execute the T cell shape
changes associated with T cell activation. However, upon overex-
pression of PIP5K c90, ERM phosphorylation dropped significantly
less (c90)(p#0.01) to only 6665% of the level of non-stimulated T
cells (Fig. 5). Overall ERM expression was not altered by PIP5K
overexpression (Fig. S5A). We thus suggest as a mechanism of
PIP5K-dependent T cell rigidification that elevated PIP2 generation
inhibits ERM inactivation upon T cell activation. Upon knockdown
of PIP5K c, T cell stimulation triggered slightly enhanced reduction
Figure 2. PIP5K overexpression alters PIP2 levels and localization. A. PIP2 levels were determined by immunofluorescence staining of 5C.C7
T cells transduced with different GFP-tagged PIP5K isoforms as indicated. PIP2 levels of T cells with PIP5K overexpression (grey bars) and control (black
bars) are normalized to control and are given with standard errors for two independent experiments each. An asterisks indicates statistical
significance versus control with p,0.005. 100–200 cells were analyzed per experiment. A representative PIP2 staining experiment is shown as Fig.
S2D. B. 5C.C7 T cells were transduced to express PLCd PH-GFP and activated with CH27 APCs and 10 mM MCC agonist peptide. The graph shows the
percentage of cell couples with standard errors that displayed accumulation of PLCd PH-GFP with the indicated patterns [6] relative to tight cell
coupling. 60 cell couples were analyzed. C, D. Similar to B, the panels show patterning data for 5C.C7 T cells expressing PLCd PH-GFP with concurrent
overexpression of PIP5K b (C) or c90 (D). 41, 26 cell couples were analyzed per condition. Representative images for panels B–D are given in Fig. S2E–
G. Representative movies have been published (c87 [6]) or are given as Movies S4, S5, S6.
doi:10.1371/journal.pone.0027227.g002
Figure 3. Manipulation of PIP5K expression affects IL-2 secretion and proximal signal transduction. A, B. 5C.C7 T cells were activated by
CH27 APCs and 10 mM MCC agonist peptide for 16 h upon manipulation of PIP5K expression and PIP2 blockade as indicated. Cell culture
supernatants were analyzed for IL-2 by ELISA. A representative IL-2 ELISA is given in (A). Changes in IL-2 secretion upon manipulation of PIP5K
expression and PIP2 blockade relative to non-transduced T cells are given with standard errors in (B) on a logarithmic scale to comparably display
reduction and enhancement. ‘GFP’ indicates retroviral expression of GFP as a control. One/two asterisks indicate significance versus non-transduced
control with p,0.05/0.005, respectively. Data from 3–6 independent experiments are given. When the agonist peptide concentration during T cell
activation was reduced to a limiting concentration, 0.1 mM, knockdown of PIP5K c still did not result in impaired IL-2 secretion (Fig. S3). C, D. 5C.C7 T
cells were activated by CH27 APCs and 10 mM MCC agonist peptide for 2 min upon manipulation of PIP5K expression as indicated. T cell/APC extracts
were blotted for LAT Y191 and PLCc Y783. A representative blot is given in (C). Changes in LAT and PLCc phosphorylation upon manipulation of
PIP5K expression relative to non-transduced T cells are given with standard errors in (D) on a logarithmic scale to comparably display reduction and
enhancement. Data from 3–4 independent experiments are given.
doi:10.1371/journal.pone.0027227.g003
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(Fig. 5, not significantly different from control however) as consistent
with unimpaired T cell flexibility. A reduced frequency of T cell
coupling and impaired F-actin polymerization could be ruled out as
alternate mechanisms of PIP2 action (Fig. S5B, C).
The spatiotemporal organization of T cell signaling
depends on PIP2
To understand how T cell rigidity may be linked to T cell
signaling, we addressed effects of PIP2 on TCR clustering. TCR
clustering as a representative element of the system wide
Figure 4. PIP5K overexpression rigidifies T cells. A. 5C.C7 T cells were activated with CH27 APCs and 10 mM MCC agonist peptide. The
diameter of the T cell/APC interface at the time of tight cell coupling is given with standard errors relative to that of the T cell body upon
manipulation of PIP5K expression as indicated. An asterisk indicates statistical significance with p,0.01 relative to control. 28–54 cell couples were
analyzed per condition. B. 5C.C7 T cells were transduced to express TCRf-GFP and were activated with CH27 APCs and 10 mM MCC agonist peptide.
For all cell couples with persistent interface accumulation of TCRf-GFP it was determined whether preceding cell coupling occurred with (e.g. Figs.
S1C, S2E, and S6A) or without (Fig. S4A, Movie S7) the formation of a visible lamellum. Of all T cell/APC couples with persistent TCRf-GFP interface
accumulation, the percentage of cell couples without visible lamellum upon cell coupling is given with standard errors upon manipulation of PIP5K
expression, as indicated. An asterisk indicates statistical significance with p,0.001 relative to control. 25–56 cell couples were analyzed per condition.
C. 5C.C7 T cells were activated with CH27 APCs and 10 mM MCC agonist peptide. The percentage of cell couples with a visible uropod is given with
standard errors relative to tight cell coupling upon manipulation of PIP5K expression and PIP2 blockade, as indicated. 17–68 cell couples were
analyzed per condition.
doi:10.1371/journal.pone.0027227.g004
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cytoskeletal dynamics [37,38], and is thus likely to be influenced by
ERM-regulated cytoskeleton plasma membrane interactions.
Upon tight cell coupling, the TCR is recruited to the T cell/
APC interface with a preference for the interface center. In the
activation of 5C.C7 T cells by APCs such central clustering is
related to the efficiency of T cell signaling [6,7]. Moreover, TCR
clustering has a strong distal component as in about half of the cell
couples the TCR is recruited transiently to the T cell distal pole
[6](Figs. 6A, S6A). Rapid release of the TCR from the distal pole
is associated with increasing interface accumulation.
Overexpression of PIP5K b and c90 interfered with TCR
accumulation at the T cell/APC interface within the first minute
of tight cell coupling (Figs. 6B, C, S6B, C). For example upon
overexpression of PIP5K c90, interface accumulation of the TCR
in any pattern and in a central pattern at 1 min was reduced from
7966% and 4968% of control T cell/APC couples with such
accumulation to 4268% and 1766%, respectively (p,0.005)
(Fig. 6B). Delayed interface accumulation was accompanied by
delayed TCR release from the distal pole. For example at 2 min
no distal pole accumulation was observed in control T cell/APC
couples any more, while in cell couples with T cell overexpression
of PIP5K c90 or b 3368% and 865% of cell couples,
respectively, still displayed distal accumulation of the TCR
(p#0.01)(Fig. 6B, C). The phenotype upon PIP5K b overexpres-
sion was most complex, as both the inducible recruitment of the
TCR to the distal pole and the subsequent release were defective
(Fig. 6C). Intriguingly, the severity of the defects in the early
spatiotemporal organization of T cell signaling upon overexpres-
sion of the different PIP5K isoforms matched the degree of
impairment of IL-2 secretion, in that distal PIP5K isoforms were
most effective. Effects of overexpression of PIP5K c87 (Fig. S6D,
E), PIP5K c knockdown (Fig. S6F, G), and PIP2 blockade (Fig.
S6H, I) were less severe to not significant, again consistent with
data on IL-2 secretion.
The TCR localization experiments tie our data together into a
consistent scenario of how cytoskeletal roles of PIP2 control T cell
activation: Increased rigidity of the T cell upon PIP5K
overexpression (Figs. 4, S4) could trap the TCR, in particular at
the distal pole (Fig. 6), thus delaying and impairing the formation
of a TCR-anchored signaling complex at the center of the T cell/
APC interface (Fig. 6). A smaller interface would also limit
receptor engagement. Less central TCR clustering and receptor
engagement is linked to less efficient proximal signaling in 5C.C7
T cell/APC couples [6,7], as also seen here (Fig. 3C, D), and thus
to less IL-2 secretion (Fig. 3A, B).
Figure 5. PIP5K overexpression interferes with ERM dephosphorylation. A, B. 5C.C7 T cells were activated with a-CD3 and a-CD28
antibodies for 1 or 2 min upon manipulation of PIP5K expression as indicated. T cell extracts were blotted for phospho-Ezrin T567/Radixin T564/
Moesin T558. Representative blots are given in (A). Phospho-ERM levels after two minutes of T cell activation are given with standard errors relative to
those of T cell extracts from non-stimulated, non-transduced T cells in (B). Modest differences in ERM phosphorylation prior to T cell stimulation were
not significant. Data from 3–10 independent experiments are given.
doi:10.1371/journal.pone.0027227.g005
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Here we have addressed two principal challenges in PIP2
biology in the activation of primary T cells. First, we found that
changes in PIP2 levels affect T cell activation primarily through
regulation of T cell rigidity and spatiotemporal organization, not
through the role of PIP2 as a substrate in second messenger
generation. Increased amounts of PIP2 did not yield increased IL-2
secretion, as to be expected for a central role of PIP2 as the
substrate of PLCc, but they resulted in substantially less IL-2
secretion. This decrease matched a series of data generated here,
as summarized in Table S1. Increased PIP2 yielded a more rigid T
cell, a T cell with delayed and impaired clustering of the TCR at
the center of the T cell/APC interface, and impaired proximal T
cell signaling. Importantly, these observations have previously
been linked using the same experimental system. In the activation
of 5C.C7 T cells by APC plus peptide, TCR clustering is
dependent on intact actin dynamics that also regulate cell shape
[37,38] and central TCR clustering is related to efficient proximal
signaling [6,7]. In addition, the effects of altered PIP2 generation
were comparably spatially constrained. Increased generation of
PIP2 at the T cell distal pole as opposed to at the T cell/APC
interface consistently had the strongest effects. While all PIP5K
isoforms controlled T cell rigidity at the interface, consistent with
their shared role in regulating cellular PIP2 levels, only the distal
isoforms also rigidified the distal pole. Initial recruitment of the
TCR to distal pole, its release and its central accumulation were all
more dependent on the distal PIP5K isoforms, as were proximal
signaling and IL-2 secretion. The shared spatial constraint further
strengthens the functional connections between T cell rigidity,
organization, and function. Significantly, it links spatial features of
PIP2 turnover to those of PIP2 function. Our data thus establish
that PIP2 regulates T cell activation primarily through spatially
constrained control of T cell rigidity and spatiotemporal
organization, thus forming a first critical foundation for future
more detailed work on roles of PIP2 in T cell activation.
As a second general challenge, we have determined the
spatiotemporal features of PIP2 synthesis as a critical part of a
more comprehensive understanding of PIP2 turnover as resolved
in time and space. Different PIP5K isoforms were enriched at the
T cell/APC interface or the T cell distal pole with distinct local
preferences and dynamics. As part of a larger analysis of the
spatiotemporal organization of T cell signaling [6], the following
picture emerges: The T cell/APC interface likely is the site of most
intense PIP2 turnover. Not only are the two most abundant PIP5K
isoforms (c87 and a) enriched there, but also two key enzymes in
PIP2 metabolism, PLCc and PI3K. Based on the observed
distributions of free PIP2, PIP2 synthesis dominated during the first
minute of cell coupling, PIP2 metabolism thereafter. The distal
pole in contrast is likely a site of slower PIP2 turnover. It displayed
enrichment of only the less abundant PIP5K isoforms and none of
PIP2 metabolizing enzymes. Nevertheless, initial PIP2 metabolism
still seems active, as accumulation of accessible PIP2 after T cell/
APC coupling was only transient (Fig. 2B). However at later time
points, overexpression of the distal PIP5K b isoform yielded stable
accumulation of free PIP2 at the distal pole (Fig. 2C), indicative of
slowed PIP2 turnover and something not seen at all at the T cell/
APC interface upon overexpression of interface-associated PIP5K
isoforms. Slower turnover of distal PIP2 at later time points is
consistent with the stable accumulation of the PIP2-binding ERM
at the distal pole, as opposed to no or only transient accumulation
at the T cell/APC interface [35]. This initial characterization of
PIP2 turnover as resolved in time and space forms a second critical
foundation for future more detailed work on roles of PIP2 in T cell
activation.
Materials and Methods
Ethics Statement
All mouse studies have been approved by the UT Southwestern
Medical Center Institutional Animal Care and Use Committee
under protocol 2010-0224 and were executed in accordance with
the USDA Animal Welfare Act.
Cells and reagents
In vitro primed, primary T cells from 5C.C7 TCR transgenic
mice were generated as described [37]. CH27 cells were used as
APCs [37]. PIP5K-GFP fusion proteins were generated as fusions
of GFP to the N-terminus of PIP5K. Actin-GFP, TCRf-GFP,
PLCd PH-GFP have been described [6]. Retroviral transduction
was performed as described [37]. T cells that retrovirally express
fluorescent sensor proteins were FACS sorted for a consistent and
low expression level. Through quantitative immnuoblotting with
anti-GFP antibodies of cell extracts from the sorted T cells against
dose responses of pure GFP, this sensor expression level was
determined to be 5 mM [6]. For shRNA-mediated knockdown of
PIP5K c, a RNA polymerase II-driven cassette for parallel
expression of an shRNA hairpin and a marker protein [39] was
cloned into the MMLV-based retroviral vector. For retroviral
expression of PIP5K together with imaging sensors from the same
mRNA, sensor translation was initiated on an EMCV-based
internal ribosomal entry site. The following antibodies were used:
antibodies against phospho-LAT Y191, phospho-PLCc Y783,
Ezrin/Radixin/Moesin, phospho-Ezrin T567/Radixin T564/
Moesin T558 (Cell Signaling, Danvers, MA), PIP5K c (Epitomics,
Burlingame, CA) antibodies against CD3 (2C11) and CD28 (BD
Pharmingen), and polyclonal rabbit anti-PIP5K c90 [40] and
mouse anti-PIP2 sera (a kind gift from K. Fukami, U. Tokyo).
Alexa Fluor 594 phalloidin was from Molecular Probes (Eugene,
OR). A protein transduction version of the PLCd PH domain was
generated, purified under native conditions from E. coli by
immobilized metal affinity chromatography, and applied to T cells
in strict analogy to [41].
Image acquisition and image analysis
Image acquisition and analysis were performed as described in
great detail [6]. Briefly, T cell-APC interactions were imaged at
37uC. Every 20 seconds, 1 DIC and 21 fluorescence images that
spanned 20 mm in the z-plane at 1 mm intervals were acquired.
The acquisition and analysis software was Metamorph (Molecular
Devices). The formation of a tight cell couple, time 0 in our
analysis, was defined as either the first time point with a fully
spread T cell-APC interface or 40 s after first membrane contact,
Figure 6. PIP5K overexpression interferes with accumulation of the TCR at the center of the T cell/APC interface. A. 5C.C7 T cells were
transduced to express TCRf-GFP and activated with CH27 APCs and 10 mM MCC agonist peptide. The graph shows the percentage of cell couples
with standard errors that displayed accumulation of TCRf-GFP with the indicated patterns [6] relative to tight cell coupling. 45 cell couples were
analyzed. B, C. Patterning data for 5C.C7 T cells expressing TCRf-GFP upon concurrent overexpression of PIP5K c90 (B) or b (C) are displayed as in (A).
36, 25 cell couples were analyzed per condition. Representative images for all three panels are given in Fig. S6A–C. Representative movies are given
as Movies S12, S13, S14.
doi:10.1371/journal.pone.0027227.g006
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defined by an average fluorescence intensity of .135% of the
background cellular fluorescence. To classify spatial accumulation
features, six mutually exclusive interface patterns were used:
central, invagination, diffuse, lamellal, asymmetric and peripheral,
as defined by strict geometrical constraints (Table 2 and actin data
in Figure S12 in [6]). Distal accumulation was scored indepen-
dently. A T cell was scored to have a uropod as long as an
inversion of curvature of the plasma membrane could be detected
at the distal pole in the DIC images. To ensure the reliability of
this analysis, data were routinely analyzed by two investigators
independently.
PIP2 staining
5C.C7 T cells expressing different GFP-tagged PIP5K isoforms
were FACS sorted for matching numbers of GFP positive and
negative T cells, using the same sort windows as in all other
experiments. Both populations were mixed, adhered to a poly d-
lysine-coated cover slip, and stained for PIP2 as established [28].
Briefly, cells were fixed in 4% Paraformaldehyde, permeabilized
with 0.5% Saponin, and stained with an anti-PIP2 antiserum and
an anti-mouse antibody conjugated to Alexa 568. Signal was .20-
fold above non-specific staining background. Three-dimensional
images of the stained cells were acquired and 100–200 cells per
experiment were analyzed for PIP2 staining intensity, separately in
the same field for GFP positive and negative cells: T cells were
identified by intensity thresholding and the integrated Alexa 568
fluorescence was measured as a readout of total cellular PIP2
amounts.
Biochemical and functional assays
To determine PIPI5K mRNA levels, cDNA from primary
5C.C7 T cells was analyzed by real time PCR using SYBR Green
labeling and the Applied Biosystems 7300 real time PCR system
with b2-microglobulin as the quantification standard. cDNA was
prepared using the RNA STAT-60 reagent (Tel Test, Inc.) and
SuperScript reverse transcriptase (Invitrogen) according to man-
ufacturer’s instructions. Phosphorylation of LAT and PLCc was
determined by Western blotting of cell extracts from T cell/APC
couples, as described [6]. The phosphorylation of ERM proteins
was similarly determined after T cell stimulation for 2 min with
10 mg/ml a-CD3 and a-CD28 and secondary antibody cross-
linking. ERM and PIP5K c expression were determined similarly
in cell extracts from non-stimulated cells. Staining with Alexa 594
phalloidin was performed according to the instructions provided
by the manufacturer. IL-2 was measured in T cell/APC culture
supernatants after 16 h of cell contact using the OptEIA kit from
DB Biosciences according to the instructions provided by the
manufacturer as scaled down to as few as 10,000 sorted T cells.
Supporting Information
Figure S1 Different PIP5K isoforms display distinct
spatiotemporal patterns. A. The mRNA abundance of
different PIP5K isoforms in 5C.C7 T cells was determined by
real time PCR with b2 microglobulin mRNA as a standard and is
given relative to the amount of b2 microglobulin mRNA with
standard errors as indicated. Averages of 5–6 independent
experiments are given. PIP5K b mRNA could be detected only
once. B–E. Representative interactions of 5C.C7 T cells
transduced with PIP5K c87-GFP (B), a-GFP (C), b-GFP (D),
and c90-GFP (E) with CH27 APCs in the presence of 10 mM
MCC peptide are shown at the indicated time points (in minutes)
relative to the time of tight cell coupling. Differential interference
contrast (DIC) images are shown on top, with top-down,
maximum projections of 3-dimensional GFP fluorescence data at
the bottom. GFP fluorescence intensity is displayed in a rainbow-
like false-color scale (increasing from blue to red). Movies covering
the entire time frames are in [6](for PIP5K c87) and as Movies S1,
S2, S3.
(EPS)
Figure S2 PIP5K overexpression alters PIP2 levels and
localization. A, B. To determine spatiotemporal distributions of
PIP5K-GFP isoforms, 5C.C7 T cells transduced to express a
PIP5K-GFP isoform were FACS-sorted into a 5-fold range of
expression centered at 360.6 mM that is minimally required for
detection by fluorescence microscopy [6]. (A) To determine such
PIP5K-GFP expression relative to endogenous PIP5K, cell
extracts from 5C.C7 T cells expressing GFP fusions with PIP5K
c 87 or c 90 and from matching numbers of non-transduced
control cells were blotted for both PIP5K c isoforms (on top) or for
PIP5K c90 only (on the bottom). Representative blots are shown.
A suitable antibody against the b isoform is not available. (B) Based
on previous calibration of GFP fluorescence intensity as a function
of GFP expression [6](experimental procedures) endogenous
PIP5K c expression was calculated using the ratio of band
intensities for PIP5K c-GFP and PIP5K c and is given with
standard errors based on at least 2 independent experiments. C. In
many experiments throughout this manuscript non-fluorescent
PIP5K isoforms were overexpressed alongside imaging sensors
using the same retroviral vector backbone used for the expression
of the GFP-tagged PIP5K isoforms only. T cells expressing non-
fluorescent PIP5K and a sensor where then sorted for low sensor
expression, as established [6]. This resulted in expression levels of
overexpressed non-fluorescent PIP5K similar to that of PIP5K-
GFP: Cell extracts from 5C.C7 T cells expressing PIP5K c87-GFP
or PIP5K c87 together with TCRf-GFP and from matching
numbers of non-transduced control cells were blotted for both
PIP5K c isoforms. One representative blot is shown. D. A
representative PIP2 staining experiment is shown. FACS-sorted T
cells expressing PIP5K b-GFP and non-transduced control cells
were mixed in equal numbers, fixed, and stained with anti-PIP2
antiserum followed by an Alexa 568-conjugated secondary
antibody. A series of matching bright field, GFP, and Alexa 568
images is shown. E. A representative interaction of a PLCd PH-
GFP-transduced 5C.C7 T cell with a CH27 APC in the presence
of 10 mM MCC peptide is shown as in Fig. S1B. A movie covering
the entire time frame is in [6]. F–H. Similar to E, the panels show
representative interactions for 5C.C7 T cells expressing PLCd PH-
GFP with concurrent overexpression of PIP5K b (F), PIP5K c90
(G), or PIP5K c87 (H). Movies covering the entire time frame are
given as Movies S4, S5, S6. I. Similar to Fig. 2B, the panel shows
patterning data for 5C.C7 T cells expressing PLCd PH-GFP with
concurrent overexpression of PIP5K c87. Given is the percentage
accumulation of PLCd PH-GFP with standard errors with the
indicated patterns [6] relative to tight cell coupling. 29 cell couples
were analyzed. J. For shRNA-mediated knockdown of the PIP5K
c isoforms, we used a retrovirally-expressed hairpin that targets
both the c87 and the c90 isoforms. shRNA-mediated knockdown
reduced PIP5K c90 expression by 56621% (p=0.05). A
representative Western blot is shown. Knockdown of combined
PIP5K c87/c90 was less, not reaching significance any more. PIP2
levels as determined by immunofluorescence similar to Fig. 2A
were reduced by about 5% (not reaching statistical significance),
consistent with tight regulation of PIP2 levels. K. To block PIP2,
PLCd PH was employed as an E. coli expressed protein
transduction reagent (‘tatPLCd PH’). Effects of tatPLCd PH on
T cell activation were highly dose-dependent, consistent with tight
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substantial effects could not be found, at .5 mM tatPLCd PH T
cell coupling upon APC contact was reduced by .65% (p,0.001)
from 5065% to less than 20%. This was most likely caused by
a.95% decrease (p,0.001) in the percentage of T cells with overt
migratory polarity. We therefore used tatPLCd PH at 5 mM, the
maximal concentration allowing effective cell coupling. To directly
assess the efficacy of 5 mM tat PLCd PH, we tested its ability to
compete with PLCd PH-GFP FACS-sorted to a concentration of
2 mM. Similar to Fig. 2B, the panel shows patterning data for
5C.C7 T cells expressing PLCd PH-GFP with concurrent PIP2
blockade by T cell pretreatment with 5 mM tat PLCd PH. Given is
the percentage of cell couples with standard errors that displayed
accumulation of PLCd PH-GFP with the indicated patterns [6]
relative to tight cell coupling. Only 14 cell couples could be
analyzed. Preincubation of T cells with 5 mM tatPLCd PH made
interface PLCd PH-GFP accumulation moderately but signifi-
cantly more transient with reduced accumulation at the time of
tight cell couple formation (8365% to 50613%, p,0.005) and
80–120 s thereafter (6064% to 4368%, p=0.05), thus defining
the efficacy of tatPLCd PH.
(EPS)
Figure S3 Manipulation of PIP5K expression affects IL-
2 secretion. To determine whether reduced PIP2 generation
would interfere with T cell activation at limiting activation
conditions, 5C.C7 T cells were activated by CH27 APCs in the
presence of 0.1–10 mM MCC peptide as indicated for 16 h upon
knockdown of PIP5K c. Cell culture supernatants were analyzed
for IL-2 by ELISA and data are displayed similar to Fig. 3B. Data
from 3 independent experiments are given.
(EPS)
Figure S4 PIP5K overexpression rigidifies T cells. A.
5C.C7 T cells transduced with TCRf-GFP and PIP5K c87 were
activated with CH27 APCs and 10 mM MCC agonist peptide. Two
interactions of such T cells binding to the same APC at the center of
the image with no (top) or a very small (bottom) visible lamellum are
shown as in Fig. S1B. The time of tight cell coupling could only be
guessed. A movie covering the entire time frame is given as Movie
S7. B. To distinguish between effects of PIP5K b and c90 in uropod
retraction, we counteracted PIP5K overexpression by parallel
expression of PLCd PH-GFP. Only PIP5K b-overexpressing T cells
still showed delayed uropod retraction: 5C.C7 T cells transduced
with PLCd PH-GFP were activated with CH27 APCs and 10 mM
MCC agonist peptide. The percentage of cell couples with a visible
uropod is given with standard errors relative to tight cell coupling
upon manipulation of PIP5K expression, as indicated. 19–74 cell
couples were analyzed per condition. The most severe effect of
PIP5K b overexpression on uropod retraction is consistent with its
exclusive distal localization (Fig. 1C). C, F, I, K. As T cell spreading
(Fig.4A) isactin-driven,weassessedchanges inT cellactindynamics
upon manipulation of PIP2 generation and access. Representative
interactions of actin-GFP-transduced 5C.C7 T cells with CH27
APCs in the presence of 10 mM MCC peptide are shown as in Fig.
S1B for a control (C), upon overexpression of PIP5K b (F), upon
PIP5K c knockdown (I), or upon T cell pretreatment with 5 mMt a t
PLCd PH (K). Movies covering the entire time frame are given as
Movies S8, S9, S10, S11. D, E, G, H, J, L. 5C.C7 T cells were
transduced to express actin-GFP and activated with CH27 APCs
and 10 mM MCC agonist peptide. The graphs show the percentage
of cell couples with standard errors that displayed accumulation of
actin-GFP with the indicated patterns [6] relative to tight cell
coupling upon manipulation of the expression of PIP5K and PIP2
blockade as indicated. 29–60 cell couples were analyzed per
condition. In non-transduced control T cells, actin rapidly and
transiently spread to the periphery of the T cell/APC interface (C,
D). At the time of tight cell couple formation 6866% of cell couples
displayed peripheral actin accumulation (D). The percentage of cell
couples with peripheral accumulation rapidly declined to 1365% at
3 min. Overexpression of PIP5K b, c87, or c90 all interfered with
actin spreading to the interface periphery (E–H). The frequency of
peripheralaccumulationwasreduced with a concomitantincrease in
diffuse patterning. For example upon overexpression of PIP5K c90,
at the time of tight cell coupling the percentage of cell couples with
peripheral actin-GFP accumulation was reduced from 6866% to
3866% (p,0.01), whereas diffuse accumulation was increased from
1665% to 3566% (p=0.01)(D, G). Such differences were
significant (p,0.05) at most time points between tight cell coupling
and 2 min thereafter in the comparison of control T cells with T cell
overexpressing each of the PIP5K isoforms. Knockdown of PIP5K c
promoted peripheral actin accumulation by making it more
sustained (I, J). From 1 to 5 min after tight cell coupling the
percentage of cell couples with peripheral actin accumulation was
significantly(p,0.05)enhanced ateachtimepointintheknockdown
T cells compared to control. Upon blocking access to PIP2 with
5 mMt a t P L C d PH (K, L), actin dynamics were largely unaltered,
consistent with intact T cell spreading (Fig. 4A).
(EPS)
Figure S5 PIP5K overexpression does not impair ERM
expression, T cell coupling, or F-actin amounts. A. To
assess whether manipulation of PIP5K expression altered ERM
expression, 5C.C7 T cell extracts were blotted for ERM proteins.
ERM expression with standard errors upon overexpression/
knockdown of the indicated PIP5K isoforms is given relative to
non-transduced control cells. B. T cell spreading is a TCR-
dependent process. Therefore, impaired T cell spreading could be
the consequence of impaired TCR engagement. The ability of a T
cell to form a cell couple upon initial APC contact is the most
immediate readout of TCR engagement upon APC contact,
occurring in seconds. The percentage of 5C.C7 T cells that form
a tight cell couple upon contact with CH27 APCs in the presence of
10 mM MCC peptide is given with standard errors upon
overexpression of PIP5K as indicated. 61–101 cell couples were
analyzed per condition. An investigation of the modest differences
in cell coupling upon PIP5K overexpression is beyond the scope of
this study. However, because cell coupling is not reduced, it can be
safely concluded that TCR engagement was not impaired. C. T cell
rigidification could be caused by altered cellular F-actin amounts.
We therefore determined F-actin amounts by phalloidin staining
prior and past TCR engagement. T cell activation was mediated by
antibodies, as the determination of T cell F-actin amounts in T cell/
APC couples, where both cell types contain F-actin, is challenging.
5C.C7 T cells were activated with a-CD3 and a-CD28 antibodies
for 2 min upon manipulation of PIP5K expression and PIP2
blockade as indicated. F-actin contents were determined by FACS
analysis of Phalloidin-stained T cells. Mean intensity of Phalloidin
staining is displayed with standard errors relative to that of non-
transduced, non-stimulated T cells. Data from three independent
experimentsaregiven.Consistent withactin-driven T cell spreading
upon APC contact, T cell stimulation with a-CD3 and a-CD28
triggered a significant (p,0.001) increase in T cell F-actin contents
in control cells by 2363%. PIP5K overexpression and knockdown
did not substantially alter T cell F-actin amounts relative to control
neither prior nor post T cell stimulation. PIP2 blockade modestly
increased F-actin amounts prior to T cell activation (p,0.05 as
indicated with an asterisk)butnot thereafter.An investigationof this
effect is beyond the scope of this study.
(EPS)
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tion of the TCR at the center of the T cell/APC interface.
A. A representative interaction of a TCRf-GFP-transduced 5C.C7
T cell with a CH27 APC in the presence of 10 mM MCC peptide is
shown attheindicatedtime points(inminutes)relative tothe time of
tight cell coupling as in Fig. S1B. A movie covering the entire time
frame is given as Movie S12. B–I. Representative images and
patterning data for 5C.C7 T cells expressing TCRf-GFP upon
concurrent overexpression of PIP5K c90 (B), b (C), c87 (D, E), a
knockdown cassette for PIP5K c (F, G), or T cell treatment with
5 mM tat PLCd PH (H, I) are displayed as in Fig. S1B (images) or
Fig. 6A (patterning data). Movies covering the entire time frame are
given as Movies S13, S14, S15, S16, S17. 32–56 cell couples were
analyzed per condition.
(EPS)
Table S1 PIP2 controls T cell activation by regulating T cell
rigidity and spatiotemporal organization.
(DOC)
Movie S1 A representative interaction of sensor-transduced
5C.C7 T cell with a CH27 B cell lymphoma APC in the presence
of 10 mM MCC agonist peptide is shown in this and all subsequent
movies. Movies were acquired using time-lapse epifluorescence
microscopy. Differential interference contrast (DIC) images are
shown on top, with matching top-down, maximum projections of 3-
dimensional sensor fluorescence data on the bottom. The sensor
fluorescence intensity is displayed in a rainbow-like false-color scale
(increasing from blue to red). 20 s intervals in movie acquisition are
played back as 2 frames per second. The individual captions list for
eachmovie the figure it refersto,the sensorandanynon-fluorescent
additional proteins expressed by the 5C.C7 T cell, the time of T
cell/APC couple formation given both as the movie frame number
and the displayed movie time (in parentheses), and noteworthy
featuresofthemovie.MovieS1referstoFig.S1C,the5C.C7T cells
are transduced with PIP5K a-GFP, cell coupling occurs in frame 3
(1s), and prominent are a large lamellum upon cell coupling and
transient interface accumulation of PIP5K a-GFP.
(MOV)
Movie S2 Refers to Fig. S1D, the 5C.C7 T cells are transduced
with PIP5K b-GFP, cell coupling occurs in frame 7 (3s), and
prominent are a small lamellum upon cell coupling and sustained
distal accumulation of PIP5K b-GFP.
(MOV)
Movie S3 Refers to Fig. S1E, the 5C.C7 T cells are transduced
with PIP5K c90-GFP, cell coupling occurs in frame 5 (2s), and
prominent are a small lamellum upon cell coupling and initial
distal accumulation of PIP5K c90-GFP followed by late interface
accumulation.
(MOV)
Movie S4 Refers to Fig. S2H, the 5C.C7 T cells are transduced
with PLCd PH-GFP and PIP5K c87, cell coupling occurs in frame
9 (4s), and prominent is transient lamellal accumulation of PLCd
PH-GFP. The T cell transits to an adjacent APC during the
movie. Only data from the 1
st T cell/APC interaction are included
in the analysis.
(MOV)
Movie S5 Refers to Fig. S2G, the 5C.C7 T cells are transduced
with PLCd PH-GFP and PIP5K c90, cell coupling occurs in frame
5 (2s), and prominent is transient interface accumulation of PLCd
PH-GFP. It is better sustained than that in the control T cell/APC
interactions.
(MOV)
Movie S6 Refers to Fig. S2F, the 5C.C7 T cells are transduced
with PLCd PH-GFP and PIP5K b, cell coupling occurs in frame 2
(0s), and prominent is sustained distal accumulation of PLCd PH-
GFP.
(MOV)
Movie S7 Contains two T cell/APC interactions, as indicated by
the positions of the respective T cells relative to the APC. Movie
S7 refers to Fig. S4A, the 5C.C7 T cells are transduced with
TCRj-GFP and PIP5K c87, cell coupling cannot be timed
precisely, and prominent is that in particular for the T cell on top a
lamellum mediating cell coupling cannot be detected.
(MOV)
Movie S8 Refers to Fig. S4C, the 5C.C7 T cells are transduced
with actin-GFP, cell coupling occurs in frame 2 (0s), and
prominent is initial peripheral actin-GFP interface accumulation
followed by variable patterns with diminishing intensity.
(MOV)
Movie S9 Refers to Fig. S4F, the 5C.C7 T cells are transduced
with actin-GFP and PIP5K b, cell coupling occurs in frame 6 (2s),
and prominent is transient diffuse actin-GFP interface accumula-
tion.
(MOV)
Movie S10 Refers to Fig. S4I, the 5C.C7 T cells are transduced
with actin-GFP and sh PIP5K c, cell coupling occurs in frame 4
(1s), and prominent is early peripheral actin-GFP interface
accumulation that is sustained in various patterns.
(MOV)
Movie S11 Refers to Fig. S4K, the 5C.C7 T cells are transduced
with actin-GFP and treated with 5 mM tat PLCd PH, cell coupling
occurs in frame 3 (1s), and prominent is transient lamellal and
diffuse actin-GFP interface accumulation.
(MOV)
Movie S12 Refers to Fig. S6A, the 5C.C7 T cells are transduced
with TCRj-GFP, cell coupling occurs in frame 7 (3s), and
prominent is rapid and sustained TCRj-GFP accumulation at the
center of the T cell/APC interface.
(MOV)
Movie S13 Refers to Fig. S6B, the 5C.C7 T cells are transduced
with TCRj-GFP and PIP5K c90, cell coupling occurs in frame 6
(2s), and prominent is initial distal with delayed central TCRj-
GFP accumulation.
(MOV)
Movie S14 Refers to Fig. S6C, the 5C.C7 T cells are
transduced with TCRj-GFP and PIP5K b, cell coupling occurs
in frame 5 (2s), and prominent are delayed weak central TCRj-
GFP interface accumulation and subsequent removal of TCRf-
GFP from the interface with accumulation in internal structures,
likely vesicles.
(MOV)
Movie S15 Refers to Fig. S6D, the 5C.C7 T cells are transduced
with TCRj-GFP and PIP5K c87, cell coupling occurs in frame 4
(1s), and prominent is delayed accumulation of TCRj-GFP at the
center of the T cell/APC interface.
(MOV)
Movie S16 Refers to Fig. S6F, the 5C.C7 T cells are transduced
with TCRj-GFP and sh PIP5K c, cell coupling occurs in frame 3
(1s), and prominent is transient accumulation of TCRj-GFP at the
center of the T cell/APC interface.
(MOV)
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with TCRj-GFP and treated with 5 mM tat PLCd PH, cell
coupling occurs in frame 7 (3s), and prominent is sustained central
TCRj-GFP interface accumulation without initial distal accumu-
lation.
(MOV)
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